Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men.

Int J Geriatr Psychiatry

Oxford Project To Investigate Memory and Ageing, Department of Pharmacology, Radcliffe, Infirmary, Oxford, UK.

Published: October 2002

Objectives: To assess the association between testosterone levels and APOEepsilon4 in cases with AD and controls.

Method: We included 61 men with definite or probable Alzheimer's disease (AD) and 55 elderly male controls from the Oxford Project to Investigate Memory and Ageing (OPTIMA). Testosterone was measured using a competitive enzyme immunoassay (Bayer).

Results: We found that both low serum testosterone and the interaction between testosterone and APOEepsilon4 were associated with AD. Furthermore, testosterone levels were lower in APOEepsilon4-positive controls (mean: 11.3 nmol/L) than in controls without the allele (19.1 nmol/L).

Conclusions: Low testosterone is potentially a modifiable risk factor, which may prove relevant to APOEepsilon4 carriers who are at risk of AD.

Download full-text PDF

Source
http://dx.doi.org/10.1002/gps.714DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
8
testosterone levels
8
testosterone
7
apolipoprotein epsilon4
4
epsilon4 testosterone
4
testosterone interact
4
interact risk
4
risk alzheimer's
4
disease men
4
men objectives
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!